Vycor Medical (VYCO) Total Current Liabilities (2010 - 2026)
Vycor Medical's (VYCO) quarterly Total Current Liabilities came in at $4.9 million in Q1 2026, up 6.33% year-on-year from $4.7 million in Q1 2025, and up 3.48% on a QoQ basis from $4.8 million in Q4 2025.
Vycor Medical (VYCO) Total Current Liabilities (2010 - 2026) Analysis & Trends
Vycor Medical (VYCO) has 17 years of Total Current Liabilities data on file, last reported at $4.9 million in Q1 2026.
- On a quarterly basis, Total Current Liabilities rose 6.33% year-over-year to $4.9 million in Q1 2026; TTM through Mar 2026 was $4.9 million, a 6.33% increase from a year earlier, with the FY2025 full-year figure at $4.8 million, up 6.34% from the prior year.
- Total Current Liabilities for Q1 2026 stood at $4.9 million, up from $4.8 million in the prior quarter.
- Over the last five years, Total Current Liabilities for VYCO reached as high as $4.9 million in Q1 2026 and fell as low as $3.4 million in Q1 2022.
- Historically, Total Current Liabilities has averaged $4.2 million across 5 years, with a median of $4.3 million in 2024.
- Across the five-year window, Total Current Liabilities advanced 16.58% in 2022 and grew 5.76% in 2025, its largest moves.
- Year by year, Total Current Liabilities stood at $3.7 million in 2022, then grew by 11.48% to $4.1 million in 2023, then grew by 10.36% to $4.5 million in 2024, then advanced by 6.34% to $4.8 million in 2025, then rose by 3.48% to $4.9 million in 2026.
- Per Business Quant data, the three most recent Total Current Liabilities figures were $4.9 million in Q1 2026, $4.8 million in Q4 2025, and $4.8 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 18.38 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 6.32 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 11.66 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 4.57 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 1.41 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 2.22 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 8.70 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 8.53 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 1.60 Bn |
| 10 | Vycor Medical | 2.34 Mn | 2.16 Mn | 375,153.00 | 4.95 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.95 Mn |
| Dec 31, 2025 | 4.78 Mn |
| Sep 30, 2025 | 4.82 Mn |
| Jun 30, 2025 | 4.58 Mn |
| Mar 31, 2025 | 4.65 Mn |
| Dec 31, 2024 | 4.50 Mn |
| Sep 30, 2024 | 4.55 Mn |
| Jun 30, 2024 | 4.31 Mn |
| Mar 31, 2024 | 4.26 Mn |
| Dec 31, 2023 | 4.07 Mn |
| Sep 30, 2023 | 4.03 Mn |
| Jun 30, 2023 | 3.78 Mn |
| Mar 31, 2023 | 3.79 Mn |
| Dec 31, 2022 | 3.65 Mn |
| Sep 30, 2022 | 3.62 Mn |
| Jun 30, 2022 | 3.36 Mn |
| Mar 31, 2022 | 3.35 Mn |
| Dec 31, 2021 | 3.15 Mn |
| Sep 30, 2021 | 3.11 Mn |
| Jun 30, 2021 | 3.04 Mn |